Evidence map›Paper›PMID 42043623›Full record

ReviewCurrent pain and headache reports2026

Medication Overuse Headache in Children and Adolescents: A Narrative Review.

Joshua Ransick, Juliana VanderPluym

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pain and headache reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joshua RansickMayo Clinic Arizona, Scottsdale Arizona, USA. Ransick.Joshua@mayo.edu.
Juliana VanderPluymMayo Clinic Arizona, Scottsdale Arizona, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewMedication overuse headache (MOH) is a secondary headache disorder that occurs in patients with pre-existing primary headache disorders who frequently use acute headache medications. While management strategies for MOH have been increasingly studied in adults, there remains limited data guiding diagnosis and treatment in children and adolescents. This review summarizes recent evidence on the epidemiology, medication patterns, and management strategies for pediatric MOH and compares these findings with the adult literature. RECENT

findingsThrough our literature search over the past 5 years, we revealed only 2 studies evaluating treatment strategies in MOH in pediatrics. Recent epidemiologic studies of pediatric MOH revealed an increased impact to quality of life, time spent in ictal state, and absenteeism compared to peers with other primary headache disorders. Despite its impact on quality of life and school attendance, pediatric MOH remains understudied. Larger prospective studies are needed to determine optimal treatment strategies and improve evidence-based management in this population.

Indexed as

AnalgesicsHeadache Disorders, SecondaryAdolescentChildHumansQuality of LifeAnalgesicsHeadache disordersHeadache epidemiologyMedication overuse headachePediatric headache

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.